scholarly article | Q13442814 |
P356 | DOI | 10.1002/PROS.23290 |
P698 | PubMed publication ID | 27976414 |
P50 | author | Timothy Synold | Q78536675 |
P2093 | author name string | Ye Zhou | |
Susan Markel | |||
Ben Copeland | |||
Jeremy O Jones | |||
Maya Otto-Duessel | |||
Miaoling He | |||
P2860 | cites work | Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival | Q21091046 |
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth | Q28116222 | ||
Molecular determinants of resistance to antiandrogen therapy | Q28236889 | ||
Generation of a prostate from a single adult stem cell | Q28298344 | ||
Macrophage biology in development, homeostasis and disease | Q29620350 | ||
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer | Q33235187 | ||
Macrophage polarization in inflammatory diseases | Q33716370 | ||
The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction | Q34127128 | ||
The diversity of sex steroid action: novel functions of hydroxysteroid (17β) dehydrogenases as revealed by genetically modified mouse models. | Q34229472 | ||
Adrenarche: A Survey of Rodents, Domestic Animals, and Primates | Q34361264 | ||
Role of endocytosis in cellular uptake of sex steroids. | Q34448507 | ||
A luminal epithelial stem cell that is a cell of origin for prostate cancer | Q35001982 | ||
Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer | Q35173046 | ||
M1 and M2 macrophages: the chicken and the egg of immunity | Q35600855 | ||
Hormones and prostate carcinogenesis: Androgens and estrogens | Q35687198 | ||
Testosterone as a predictor of pathological stage in clinically localized prostate cancer | Q35758294 | ||
Novel Markers to Delineate Murine M1 and M2 Macrophages | Q35877268 | ||
Sex steroid hormone metabolism and prostate cancer | Q36017042 | ||
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. | Q36140754 | ||
Is dehydroepiandrosterone a hormone? | Q36315402 | ||
Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination | Q36544966 | ||
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth | Q36876865 | ||
Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics | Q37016384 | ||
Non-competitive androgen receptor inhibition in vitro and in vivo. | Q37182710 | ||
Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue | Q37304966 | ||
Testosterone therapy in men with prostate cancer: scientific and ethical considerations | Q37371225 | ||
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. | Q37866912 | ||
Differing levels of testosterone and the prostate: a physiological interplay | Q37883014 | ||
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives | Q37947091 | ||
A new era of testosterone and prostate cancer: from physiology to clinical implications | Q38134914 | ||
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. | Q38349829 | ||
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study | Q38922304 | ||
Occult prostate cancer in men with low serum testosterone levels | Q39437834 | ||
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer | Q39954334 | ||
Effect of Testosterone Implants on Serum Gonadotropin Concentrations in the Male Rat | Q42157575 | ||
Cell differentiation lineage in the prostate | Q42515180 | ||
High-grade prostate cancer is associated with low serum testosterone levels | Q43576700 | ||
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer | Q43991656 | ||
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy | Q44398102 | ||
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy | Q45269738 | ||
Changes in the androgen levels in the ventral prostate of spontaneously hypertensive rats after castration | Q46110945 | ||
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies | Q46784184 | ||
Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. | Q46972198 | ||
P433 | issue | 5 | |
P304 | page(s) | 530-541 | |
P577 | publication date | 2016-12-14 | |
P1433 | published in | The Prostate | Q7758608 |
P1476 | title | Low Testosterone Alters the Activity of Mouse Prostate Stem Cells | |
P478 | volume | 77 |
Q90104464 | Factors that influence the androgen receptor cistrome in benign and malignant prostate cells | cites work | P2860 |
Search more.